A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Atea Pharmaceuticals, Inc. (AVIR) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Atea Pharmaceuticals, Inc. (AVIR) on November 13, 2026 is $4.30, +2.14% on the day. Over 52 weeks the stock traded between $2.90 and $6.45; the price now sits 40% of the way up that range. Over the past year the price changed by +40.52%. Market capitalisation is $344.88 million, rank 172 among 382 stocks of the same industry with a known capitalisation.
Atea Pharmaceuticals, Inc. trades on Nasdaq under the ticker AVIR. The company belongs to the Health care sector. The trading history on this page starts on 30 October 2020.
Over the past 52 weeks AVIR has traded between $2.90 and $6.45. As of 13 November 2026 the price stood 39.52% of the way from the 52-week low to the high.
Over one year AVIR shares rose 40.52%; over six months they rose 4.88%. Volatility over 90 days is 47.54%. Dividends are not included: this is price change only, as of 13 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 1.7, below the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
AVIR has a return on equity of −80.96%, below the sector median of −40.58%. Return on assets is −71.16%, below the sector median of −30.08%.